Summary We studied the mechanism of anti-tumour action of a sulphydryl glycoprotein (SAGP) purified from an extract of Streptococcus pyogenes in vitro. SAGP rapidly inhibited the incorporation of nucleic acid precursors into murine fibrosarcoma (Meth A) cells before it inhibited the cell growth. SAGP-induced cell growth inhibition was diminished by incubating the cells with pertussis toxin (IAP), whereas the SAGP activity was augmented by incubating the cells with cholera toxin (CTX). Meth A cells exposed to SAGP underwent an increase in labelling of the a-subunit of an inhibitory guanine nucleotide-binding (Gi) protein in a subsequent IAP-catalysed [32P]ADP ribosylation of the cell membrane fraction. Gia labelling was not increased either in the membrane from the Meth A cells exposed to heat-inactivated SAGP or in the membrane from L929 cells exposed to SAGP, in which growth was also unaffected. By contrast, SAGP caused no alteration in labelling the a-subunit of stimulatory guanine nucleotide-binding (Gs) protein in a subsequent CTX-catalysed ADP ribosylation of membrane fractions of Meth A and L929 cells. The amount of intracellular cAMP was decreased slightly in Meth A cells incubated with SAGP. Although the precise roles of Gs protein and adenylate cyclase in the cell growth inhibition induced by SAGP are not clear, these findings suggested that the modulation of Gi protein is involved in such SAGP-induced cellular events as the inhibition of nucleic acid synthesis and cell growth inhibition.
In the late 1800s, William B Coley and his colleagues described the cancer therapeutic effects of erysipelas-inducing streptococci (Nauts et al., 1946; Rook, 1992; Starnes, 1992) . Laboratory studies on microbial products as anti-tumour agents led to the identification of an active substance, a lipopolysaccharide (LPS) from Gram-negative bacteria and afterwards the discovery of tumour necrosis factor (TNF) in serum of animals injected with Bacillus Calmette-Guerin (BCG) and LPS (Reilly, 1953; Old, 1985) . Meanwhile, Okamoto et al. (1978) reported that Streptococcus pyogenes showed anti-tumour activity in mice and they prepared an anti -tumour streptococcal preparation (OK-432) from a non-virulent Su strain of the cocci. We identified an acidic glycoprotein (SAGP) as having anti-tumour properties, from the Streptococcus pyogenes, Su strain (Yoshida et al., 1985) . SAGP is a glycoprotein with molecular weight of 140-150 kDa, which consists of identical subunits with a molecular weight of 48 kDa. Kanaoka et al. (1987a) compared the in vitro and in vivo anti-tumour activities of SAGP with those of OK-432 and further cloned and expressed the structural gene for SAGP in Escherichia coli (Kanaoka et al., 1987b) . We observed that SAGP inhibited the growth of some cells lines in culture, including murine embryonic cells (BALB/3T3) (Yoshida et al., 1987) , murine leukaemic L1210 (Yoshida et al., 1989) , murine fibrosarcoma Meth A (Yoshida et al., 1991) and human HL60 (unpublished data). SAGP also prolonged the life span of mice inoculated with Ehrlich ascites carcinoma cells or Meth A cells. As this effect of SAGP on the mice inoculated with these tumour cells was reduced when they were immunosuppressed by X-irradiation or with carrageenan, an anti-macrophage agent, hostmediated mechanisms were thought to be involved partly in the anti-tumour action of SAGP (Yoshida et al., 1991) . Furthermore, the studies on the SAGP-induced cell growth inhibition using thiol reactive agents suggested that SH groups on SAGP are involved in the anti-tumour action of SAGP (Yoshida et al., 1994) . The observation suggested that SAGP interacts with an unknown receptor on the target cells through its SH groups, and the signals elicit cell growth inhibition through intracellular transduction pathways. To clarify this assumption, we studied first the effect of SAGP on macromolecular synthesis in the target cells, and studied further whether or not inhibitors of several intracellular pathways affect SAGP activity. We found that the antitumour activity of SAGP on Meth A cells was modified by first exposing the cells to a bacterial toxin, pertussis toxin (IAP) or cholera toxin (CTX). We report here evidence suggesting that guanine nucleotide-binding proteins are involved in the cell growth-inhibitory action of SAGP.
Materials and methods Preparation of SAGP SAGP was prepared as described previously (Yoshida et al., 1985 (Yoshida et al., , 1994 . In brief, Streptococcus pyogenes (Su strain) cells grown in 60 1 of Wood and Gunsalus broth were collected by centrifugation and washed with 10 mM Tris-HCI buffer containing 10 mM magnesium acetate, pH 7.5 (buffer A). The cells were mechanically disrupted using a Vibrogen cell mill (Edmund Buihler, Tiubingen), extracted with buffer A, then centrifuged twice at 17 500 g for 20 min and once at 105 000 g for 2 h. The supernatant (CE) was heated (45°C, 30 min) precipitated with streptomycin, fractionated with ammonium sulphate (55-70%) and separated by sequential column chromatography on octyl-Sepharose CL-4B, DE-52 and Sephadex G-200. The anti-tumour activity of each chromatographic fraction was evaluated by the in vitro growth inhibition test using transformed hamster embryonic lung (THEL) (Yoshida et al., 1985) or L1210 cells. The active fraction from Sephadex G-200 gel filtration was dialysed against distilled water, and the precipitate was removed. The dialysate (SAGP, Figure 1) tubes. These mixtures were incubated for 60 min at 37°C, then the reaction was stopped by centrifugation at 8000 g for 2 min. The pellet w^as washed twice with ice-cold PBS, solubilised in 40 Ml of 8 mm Tris-HCl containing 1.6% (w/v) sodium dodecyl sulphate (SDS), 16% glycerol and 10% (v/v) mercaptoethanol and 0.05% (w/v) bromphenol blue, pH 6.8, then heated at 94°C for 5 min. The proteins (30 Ml) were separated by SDS-polyacrylamide gel electrophoresis according to Laemmli (1970) using 10% polyacrylamide gels. The gels were stained with Coomassie brilliant blue (Quick-CBB; Wako Pure Chemical Industries, Tokyo, Japan), destained, dried and exposed to X-ray film (Kodak XAR-5; Eastman Kodak Company, NY, USA) at -80°C.
Measurement of cAMP Meth A cells (7-8 x 105 cells) were incubated with 3.5-4 ml of medium in plastic plates (3.5 cm diameter) in the presence and absence of SAGP. After 24 h, an aliquot of the cell suspension was sampled and the cell viability was determined by trypan blue exclusion. The cultures (3.0 ml) were centrifuged at 2000 g for 5 min and the cell pellets were washed once with 5 ml of cold PBS. The cAMP was extracted with ethanol as follows: 2 ml of cold 65% (v/v) ethanol was added to the washed cell pellets, mixed with vortex mixer and centrifuged at 2000 g for 10 min. The supernatant was decanted into a test tube for evaporation. The remaining precipitate was processed again in the same manner and the second extract was added to the first. The total extract was dried in a vacuum oven at 60'C. Dried extracts were stored at -20°C until cAMP assay with an EIA system according to the manufacturer's instructions.
Statistical analysis
The data were analysed using the program package 'StatView IV' (Abacus Concepts, Berkeley, CA, USA) as indicated in the figures. P-values below 0.05 were considered significant. Results 
Effects of SAGP on the cell growth
We showed previously that SAGP inhibits the growth of Meth A cells in vitro in a concentration-dependent manner (Yoshida et al., 1991) . In this study, we have shown that the growth of L929 cells is not affected by 0.1 to 3 Mg ml-' of SAGP (Figure 2 ). Even at higher doses of SAGP (up to 100 jg ml-'), the growth of L929 cells was not affected (data not shown). We then used L929 as a cell line insensitive to SAGP in some experiments. Figure 3 shows the time course of the effect of SAGP on the growth of Meth A cells. When 0.1 uMg ml-' SAGP was added to Meth A on day 0, the growthinhibitory effect of SAGP was apparent on day 2 and gradually increased on days 3 and 4. When SAGP was removed from the culture medium on day 2 by washing the cells by centrifugation, the cells were grown again as control cultures. These results indicated that the growth inhibition of Meth A cells by SAGP was reversible and time dependent. Effects of IAP and CTX on the cell growth-inhibitory action of SAGP Figure 5 shows that the growth-inhibitory effect of SAGP on Meth A cells was diminished by first incubating the cells with IAP. When the cells were incubated with 1-100 ng ml -of IAP for 24 h, then for 72 h in the presence of 0.1 or 0.3 Mg ml-' SAGP, the effect of SAGP was slightly but significantly diminished compared with that in the control cells. By contrast, the growth-inhibitory effect of SAGP was significantly augmented in the cells that were incubated with 0.3-3.0 Mg ml-' CTX for 24 h beforehand ( Figure 6 ). Interactions between the variables of IAP and SAGP-addition were regarded as significant by the two-way analyses of variance (ANOVA) . Statistical analyses of the variables of the groups incubated with IAP, IAP and SAGP (0.1 jIg ml-l), and IAP and SAGP (0.3 ,ig ml-'), were performed by one-way ANOVA followed by Sheffe's F (*P < 0.05). (Figure 8 ). These labelled bands were not observed in the membrane fractions from the cells initially exposed to CTX (1 ,ig ml-'),
indicating that these proteins correspond to CTX substrates, the a-subunit of stimulatory GTP-binding protein (Gsa). As shown in Figure 8 , CTX-catalysed ADP ribosylation did not alter the intensity of Gsa labelling in the membrane fractions were performed by one-way ANOVA followed by Sheffe's F (*P < 0.05).
from either Meth A or L929 cells incubated with SAGP. This suggested that SAGP did not modify Gsa availability for the CTX-catalysed ADP ribosylation. Figure 9 shows that the IAP-catalysed ADP ribosylation of Gia was increased in membranes from Meth A cells incubated with SAGP, but not with heat (94°C for 30 min)- (1), (10) Figure 10 shows the cAMP contents in each culture as fmol 10-5 cells. Exposure of Meth A cells to CTX caused a 2.5-fold increase in cAMP level, whereas exposure of the cells to IAP did not cause significant accumulation of cAMP. In contrast, the cAMP level in the cells exposed to SAGP was reduced slightly with increasing concentrations of SAGP (Figure 10 ).
Discussion
The growth-inhibitory effect of SAGP on Meth A cells was reversible and time dependent (Figure 3 ). SAGP retarded cell proliferation within 1-2 days. On the other hand, SAGP reduced the incorporation of two nucleic acid precursors into Meth A cells within 24 h in a concentration-dependent manner (Figure 4a and b) . These results suggested that the inhibition of nucleic acid synthesis by SAGP may precede the cell growth inhibition. (1), (3)] for 24h. The cell membrane fractions were isolated and IAP-catalysed ADP ribosylation was studied as described in Materials and methods.
target cells through the SH groups on SAGP and that a signal produced by the interaction might be conducted through an intracellular pathway. This signal might elicit the inhibition of synthesis of nucleic acids and inhibit cell proliferation. Studies of inhibitors of several intracellular pathways revealed that the growth-inhibitory action of SAGP on Meth A cells was altered in cells incubated with IAP or CTX. The activity of SAGP was diminished in cells exposed to IAP beforehand ( Figure 5 ), but augmented by CTX (Figure 6 ). IAP catalyses ADP ribosylation of a cysteine residue in the asubunit of inhibitory GTP-binding (Gi) protein, and thereby blocks interactions between Gi protein and receptors (Katada and Ui, 1982; Murayama and Ui, 1983) . On the other hand, CTX activates stimulatory GTP-binding (Gs) protein by ADP-ribosylating an arginine residue of the a-subunit in Gs protein (Northup et al., 1980; Hepler and Gilman, 1992) . The finding that the activity of SAGP was diminished by IAP suggested the involvement of Gi protein in the expression of SAGP activity.
Accordingly, to investigate the activity of G-protein, we examined the ability of SAGP to modify the IAP or CTXcatalysed ADP ribosylation. The IAP-catalysed ADP ribosylation assay showed that SAGP caused an increase in labelling of the 41 kDa protein of Meth A membrane ( Figure  7 ). Since IAP catalyses ADP ribosylation of the a-subunit of heterotrimeric Gi protein (Katada et al., 1986) , the increase in labelled Gia indicated that SAGP may induce an abundance of heterotrimeric Gi protein or increase the susceptibility of Gia to ADP ribosylation by IAP. SAGP did not cause such an increase in labelled 41 kDa protein of L929 cells, which were SAGP insensitive in respect of growth inhibition (Figure 7 ). In addition, the increase in the labelled protein was not detected in Meth A cells incubated with heat (94°C, 30 min)-inactivated SAGP (Figure 9 ). On the other hand, there was no modification in the CTX-catalysed ADP ribosylation of Gsa in the membranes from either Meth A or L929 cells incubated with SAGP (Figure 8 ). That is, ADP ribosylation was only altered in the presence of IAP but not Figure 10 The effect of SAGP on intracellular cAMP levels. Meth A cells (2 x 105 cells ml-1) were incubated with 0.1-3.0 ig ml-n SAGP, 100 ng ml-KIAP or 1 yg ml-n CTX for 24h. al. (1988) reported that TNF induced the stimulation of GTP binding to cell membrane preparations from HL-60 and L929 cells, and the effect was associated with an increase in GTPase activity. In addition, they showed that IAP inhibited the TNF-induced increase in GTPase activity in HL-60 cells membranes and also the TNF-induced cytotoxicity to L929 cells, suggesting the involvement of IAP-sensitive GTP-binding protein in the action of TNF. We found that the growth-inhibitory effect of SAGP was diminished in cells first incubated with IAP and that SAGP specifically caused an increase in Gia protein labelling by IAP-catalysed ADP ribosylation. These findings suggested that IAP-sensitive Gi protein is involved in the expression of the SAGP activity.
We measured the intracellular cAMP contents of Meth A cells after exposure to SAGP to investigate whether or not the effects of SAGP on Gi protein are associated with modulation of adenylate cyclase. The cAMP level of these cells was slightly reduced (Figure 10 ). This does not contradict the assumption that SAGP activates Gi protein and hence reduces the intracellular cAMP level. The effect of SAGP on cAMP levels was rather small, whereas CTX caused a higher and reproducible elevation of the cAMP level owing to activation of the Gs protein. In addition, there was no significant difference between the cAMP level in the cells incubated with CTX alone and those treated with CTX plus SAGP (data not shown). At present, there is no direct evidence linking the reduction in the cAMP level to the cell growth-inhibitory action of SAGP. Other effector enzymes in the intracellular transduction system such as phospholipase C and phospholipase A2, which are associated with Gi protein Gilman, 1987; Kurachi et al., 1989; Birnbaumer et al., 1990; Bourne et al., 1990; Spriggs et al., 1990; Nakahata et al., 1991) , might be linked to the Gi protein modulated by SAGP.
At present, we do not know why the SAGP activity was augmented by CTX in Meth A cells. As Kahn and Gilman (1984) pointed out, ADP ribosylation of Gs promotes the dissociation of its a-and fly-subunits. The fly-subunits of Gs share identity with those of Gi (Gilman, 1984 (Gilman, , 1987 and play practical roles in transmembrane signal cascades (Neer and Clapham, 1988; Birnbaumer et al., 1990; 1992) . Therefore, the continuous stimulation of Gs protein by CTX might induce an alteration of LAP-sensitive G-protein or effector molecules linked to the G-protein through its dissociated flysubunits. It is possible that there is a mutual regulation between different G-protein-mediated signal pathways. In addition, in the examination of CIX-catalysed ADP ribosylation (Figure 8) Although, our interpretation of the results of the CTX and CTX-catalysed ADP ribosylation assay remains speculative, it is intresting to note that CTX augmented an external signal effect that was inhibited by IAP.
In conclusion, our findings provide the first evidence that an TAP-sensitive GTP-binding protein is involved in the cell growth-inhibitory action of SAGP. SAGP may be useful for the investigation of the signal transduction pathways in cell proliferation, and may be a novel bacterial anti-tumour glycoprotein in cancer therapy because of its immunomodulating and cell growth-inhibitory effects.
